|
Temps Différé
OTC Markets
19:54:21 11/08/2026
|
Varia. 5j.
|
Varia. 1 janv.
|
|
0,000400 USD
|
0,00%
|
 |
0,00%
|
-20,00%
|
|
07/08 |
Fifty 1 Labs Outlines Planned U.S. Telehealth Peptide Services Platform
|
AQ
| |
10/07 |
Fifty 1 Labs Announces Strategic Evolution into Peptide Biotechnology and Telehealth
|
AQ
| |
15/04 |
Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health
|
AQ
| |
14/04 |
Fifty 1 Labs, Inc. Eliminates 612 Million Shares from the Market
|
AQ
| |
05/01 |
Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace
|
AQ
| |
09/10/25 |
Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer
|
AQ
| |
30/09/25 |
Fifty 1 Labs Inc. Signs Letter of Intent to Acquire BioSpark AI Technologies Inc.
|
AQ
| |
23/09/25 |
Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB
|
AQ
| |
22/08/25 |
Fifty1 Labs, Inc. Subsidiary Fifty1 AI Labs Partners with ViRx@Stanford Under 'BE READI!' Initiative to Advance AI-Powered Antiviral Drug Repurposing
|
AQ
| |
14/08/25 |
Fifty 1 Labs, Inc. and The Gates Foundation Lead Largest-Ever Sickle Cell Disease Study, Unlocking Pathways for Gene-Based and Repurposed Therapies
|
AQ
| |
12/08/25 |
Fifty1 Labs, Inc. and BioSpark AI Unlock 2,000+ Real-World Treatment Pathways to Accelerate Functional Medicine Innovation
|
AQ
| |
29/07/25 |
Fifty 1 Labs, Inc. Hosts Successful Virtual Shareholder Teleconference, Showcasing AI-Driven Functional Medicine Strategy and World-Class Leadership
|
AQ
| |
28/07/25 |
Fifty 1 Labs, Inc. to Host Virtual Shareholder Teleconference Featuring World-Class Leadership Team, including Dr. James Orbinski, who received the Nobel Peace Prize on Behalf of Médecins Sans Frontières
|
AQ
| |
17/07/25 |
Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies
|
AQ
| |
10/07/25 |
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership
|
AQ
| |
08/07/25 |
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment
|
AQ
| |
01/04/25 |
Fifty 1 Labs, Inc. Celebrates Groundbreaking SpaceX, NASA, and ISS Yeast Experiment by Subsidiary Genetic Networks
|
AQ
| |
20/03/25 |
Fifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation
|
AQ
| |
27/02/25 |
Consumer Automotive Finance, Inc. Announces Nationwide Teleconference as It Transitions to Fifty 1 Labs, Inc.
|
AQ
| |
25/02/25 |
Consumer Automotive Finance, Inc. Finalizes Agreement to Retire 246 Million Common Shares: Strategic Move Signals Robust Commitment to Shareholder Value Enhancement
|
AQ
| |
20/02/25 |
Consumer Automotive Finance Inc. (CAFI) Completes Final Steps with FINRA, Expects Name and Ticker Change to Fifty 1 Labs, Inc. (FITY) Within 30 Days
|
AQ
| |
10/02/25 |
51 Labs Expands Sports Nutrition Line with Five New Innovative Products, Company in final phase of name and ticker symbol change
|
AQ
| |
09/12/24 |
Consumer Automotive Finance, Inc. (OTC: CAFI) Files Form 15c2-11 to Enhance Transparency and Compliance
|
AQ
| |
05/08/24 |
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement
|
PR
| |
18/06/24 |
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC
|
PR
|
Aucun résultat pour cette recherche Sélectionnez votre édition Toutes les informations financières adaptées au niveau national | 
